Speedx diagnostics

If you continue to use this site we will assume that you are happy with it. SpeeDx will endeavour to improve the health and safety of customers by continuing to invest in product development activities with the aim of producing in vitro diagnostic medical devices and research use only products for the detection of nucleic acids. The story of how SpeeDx diagnostics empower clinicians to make informed choices for their patients.

The SpeeDx product range is based on patented real-time polymerase chain reaction (qPCR) technology, driving market-leading multiplex diagnostics for sexually transmitted infections (STIs), antibiotic resistance markers and respiratory disease. In this role she leads the development of innovative diagnostic technologies and commercialization of infectious disease and antibiotic resistance tests.

Elisa Mokany is a co-founder and the Chief Technology Officer at SpeeDx. Elisa has years’ experience in medical research, she has worked for St Vincent’s hospital developing tests for. Vela Diagnostics is a worldwide supplier of integrated molecular solutions for the diagnosis of infectious diseases and cancer and innovative test and data reporting. Kostenloser Versand verfügbar. Die liebsten Fashion-Marken kaufen.

Das ist bei eBay angesagt und neu. Von Generator bis Wäsche.

Alles finden, was Sie brauchen. Wir machen die Rückgabe einfach. Provider of molecular diagnostics solutions intended to develop innovative multiplex systems for clinical diagnostics. The company uses real-time polymerase chain reaction technology for multiplex detection and priming strategies, enabling physicians to test infectious disease and antibiotic resistance. SpeeDx is an innovative Molecular Diagnostics company with class leading technology for infectious disease and antibiotic.

SpeeDx said it will work with GlaxoSmithKline on tests to support its antibiotic clinical trials, as well as its new product development efforts. US $million in additional equity investment from US-based. SpeeDx and Cepheid Announce Partnership on European Distribution Product News Jun SpeeDx Pty, Ltd.

Cepheid for distribution of its PlexPCRTM and ResistancePlusTM molecular diagnostic products in key markets throughout Europe. SpeeDx ’s ResistancePlus MG assay is the first commercially available diagnostic test that simultaneously detects M. Speedy Diagnostics is a straightforwar affordable diagnostic policy. Not everyone can afford traditional PMI cover. With reports about lengthy waiting lists still in the news, this product provides reassurance to your clients about access to prompt diagnostic tests.

Conclusions: This report provides a comprehensive insight about the epidemiology of ILIs among adults in the Qatar, as a representative of Gulf States. These would help in improvement and optimization of diagnostic procedures, as well as control and prevention of the respiratory infections.

SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. SpeeDx has developed a molecular diagnostics test portfolio, principally for infectious diseases, that provides both identification as well as therapeutic guidance capabilities. SpeeDx , a molecular diagnostics company, has received CE-IVD mark for sale of its ResistancePlus MG FleXible for the Cepheid GeneXpert System in Europe. SpeeDx said that ResistancePlus MG FleXible is used in detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) and markers associated with azithromycin resistance. Elevator Pitch: SpeeDx is a privately owned company specializing in innovative multiplex real-time polymerase chain reaction (qPCR) solutions for clinical diagnostics.

GSK, to provide a combination of existing tests and. We developed our diagnostic test to answer the immediate need for detection and resistance screening for this difficult-to-manage STI,” says Colin Denver, CEO of SpeeDx. With their reputation for scientific excellence, we are very pleased to partner with Thermo Fisher to bring this test to the US market. Applied Biosystems qPCR.

SpeeDx is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies and in vitro diagnostic tests. A key technology is the MNAzymeTM platform which provides the basis for a suite of highly sensitive and specific, and cost-effective genetic tests. SpeeDx has a suite of products, covering a range of STDs and other infectious diseases, including respiratory viruses.

SpeeDx is developing diagnostics which can detect mutations in bacterial DNA that allows clinicians to identify whether infections such as gonorrhea or mycoplasma genitalium are resistant to current antibiotic treatments. This is important as clinicians will sometimes treat patients empirically – giving them antibiotics based on their. Backers included new investor Northpond Ventures, LP – a. SpeeDx develops multiplex molecular diagnostics and will use its U. The ResistancePlus MG test detects the sexually. Australian-based diagnostic firm SpeeDx has established a U. The initial tests are for certain sexually transmitted infections, and include one that can detect SNPs conferring antimicrobial. About OLM Diagnostics OLM Diagnostics is a medical diagnostics company, which markets and distributes innovations in fungal and bacterial diagnostics to the healthcare sector.

Our novel and reliable rapid- diagnostic tests fit seamlessly into current treatment pathways and can reduce the rate of drug resistant infections by promoting a new diagnostic led approach. Streck is an ISO-certified biotech company with proven proprietary science and an unwavering commitment to the highest standards in developing and manufacturing Quality Control and diagnostic products in hematology, immunology, molecular diagnostics , infectious diseases and urinalysis for clinical and research laboratories.